Repetitive use of levosimendan in severe functional tricuspid regurgitation

Eur Heart J Acute Cardiovasc Care. 2023 May 4;12(5):336-337. doi: 10.1093/ehjacc/zuad013.

Authors

Pascal Lim^{1

2}, Julia Sharifi^{1

2}, Raphaelle Huguet^{1

2}, Romain Gallet^{1

2}, David Aouate^{1

2}

Affiliations

¹ Cardiac Intensive Care Unit and Cardiology Department, AP-HP, Henri Mondor University Hospital, 1 Rue Gustave Eiffel, 94010 Creteil Cedex, France.
² UPEC, Institut Mondor de Recherche Biomédicale, U955 Inserm, 61 Avenue du General de Gaulle, 94000 Creteil, France.

PMID: 36989396
DOI: 10.1093/ehjacc/zuad013

No abstract available

MeSH terms

Humans
Simendan / therapeutic use
Tricuspid Valve Insufficiency* / drug therapy
Tricuspid Valve Insufficiency* / surgery

Substances

Simendan